Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma

This study has been terminated.
(Study suspended)
Sponsor:
Information provided by (Responsible Party):
Washington Hospital Center
ClinicalTrials.gov Identifier:
NCT01206296
First received: September 20, 2010
Last updated: December 7, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2014
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)